Chronic myelogenous leukemia: Difference between revisions
No edit summary |
No edit summary |
||
Line 3: | Line 3: | ||
{{DiseaseDisorder infobox | | {{DiseaseDisorder infobox | | ||
Name = Chronic myelogenous leukemia | | Name = Chronic myelogenous leukemia| | ||
Image = bcrablmet.jpg|thumb| | Image = bcrablmet.jpg|thumb| | ||
Caption = The [[Philadelphia chromosome]] as seen by metaphase [[fluorescent in situ hybridization|FISH]].| | Caption = The [[Philadelphia chromosome]] as seen by metaphase [[fluorescent in situ hybridization|FISH]].| | ||
OMIM = | | OMIM =| | ||
OMIM_mult = | | OMIM_mult =| | ||
Line 47: | Line 47: | ||
[[Category:Hematology]] | [[Category:Hematology]] | ||
[[Category:Oncology]] | [[Category:Oncology]] | ||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} |
Revision as of 20:18, 6 October 2015
For patient information click here
Template:DiseaseDisorder infobox
Chronic myelogenous leukemia Microchapters |
Differentiating Chronic myelogenous leukemia from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Chronic myelogenous leukemia On the Web |
American Roentgen Ray Society Images of Chronic myelogenous leukemia |
Directions to Hospitals Treating Chronic myelogenous leukemia |
Risk calculators and risk factors for Chronic myelogenous leukemia |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor-In-Chief: Cafer Zorkun, M.D., Ph.D. [2]
Synonyms and keywords: CML; chronic myeloid leukemia; chronic myeloid leukaemia; chronic granulocytic leukemia; chronic granulocytic leukaemia; chronic myelocytic leukaemia; chronic myelocytic leukaemia.
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Chronic myelogenous leukemia from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Staging | History and Symptoms | Physical Examination | Laboratory Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Treatment Protocol | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies